MaxCyte Q1 2026 Earnings Call Transcript Highlights Commercial Platform Execution and Investor Focus

MaxCyte’s first-quarter 2026 earnings call provided a routine but important update on the cell-engineering company’s investor…

Atea Pharmaceuticals Holds Q1 2026 Earnings Call as Investors Look for Updates on Clinical Strategy

Atea Pharmaceuticals held its first-quarter 2026 earnings call on May 12, giving investors a routine update…